In a recent study posted to bioRxiv*, researchers evaluated how angiotensin-converting enzyme 2 (ACE2) expression in target cells impacts neutralization. Study: Receptor binding domain (RBD) ...
Using pseudoviruses with single amino acid substitutions, researchers found that mutations in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reduce monoclonal antibody neutralization ...
In the absence of effective treatments for COVID-19, many countries have approved the therapeutic use of blood plasma from recovering patients because it contains antibodies against the coronavirus.